Strong recommend Target Rs.900/- one yearEris Lifesciences Limited

Strong recommend Target Rs.900/- one year

Eris Lifesciences Limited is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market.

• Market Cap:  7,279 Cr.
• Current Price:  535.70
• 52 weeks High / Low  595.00 / 321.00
• Book Value:  95.45
• Stock P/E: 24.16
• Dividend Yield: 1.03 %
• ROCE: 25.33 %
• ROE: 24.22 %
• Sales Growth (3Yrs): 12.74 %
• Listed on BSE and NSE
• Company Website
• Face Value:  1.00

• PEG Ratio: 0.87
• Promoter holding: 55.55 %
• Pledged percentage: 0.00 %
• Debt:  12.14 Cr.
• Price to Earning: 24.16
• EPS:  22.04
• Net profit:  301.26 Cr.
• Profit growth: -0.77 %
• Profit growth 7Years: 26.10 %
• Net profit preceding 12months: 296.29 Cr.
• Profit growth 3Years: 6.66 %
• Dividend yield: 1.03 %
• Debt to equity: 0.01
• Sales last year:  1,074 Cr.
• Sales growth: 8.68 %
• Unpledged promoter holding: 55.55 %
• Investments:  77.98 Cr.

Quarterly Results Consolidated Figures in Rs. Crores / 

	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020
	249	209	212	251	264	252	215	274	285	266	249	293
	151	128	140	162	163	159	153	170	175	190	171	189
Operating Profit	98	81	72	89	101	94	62	105	110	77	77	104
OPM %	39%	39%	34%	35%	38%	37%	29%	38%	39%	29%	31%	35%
Other Income	6	6	7	4	6	10	12	3	5	8	-1	1
Interest	0	3	8	7	6	5	4	1	1	0	0	0
Depreciation	5	7	9	7	8	10	11	12	12	13	14	10
Profit before tax	99	77	62	78	92	89	58	95	103	72	62	95
Tax %	6%	3%	10%	8%	7%	10%	7%	11%	10%	12%	9%	6%
Net Profit	93	75	56	71	85	80	54	84	93	63	56	89
EPS in Rs	6.75	5.43	4.06	5.18	6.20	5.83	3.93	6.11	6.74	4.62	4.12	6.56
	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes

Profit & Loss Consolidated Figures in Rs. Crores /

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	TTM
	274	393	509	546	597	750	856	982	1,074	1,093
	215	307	410	424	425	480	533	637	706	725
Operating Profit	59	86	99	121	172	269	322	345	368	368
OPM %	21%	22%	19%	22%	29%	36%	38%	35%	34%	34%
Other Income	1	1	4	3	3	25	26	32	16	14
Interest	1	1	0	0	0	1	11	23	2	2
Depreciation	3	3	5	16	20	23	26	36	50	49
Profit before tax	55	83	98	109	154	270	312	317	332	331
Tax %	33%	30%	28%	18%	13%	9%	6%	8%	11%
Net Profit	37	58	70	89	134	247	294	291	296	301
EPS in Rs	2,677.03	4,217.25	5,102.83	6,466.23	8,453.33	17.95	21.39	21.15	21.60	22.04
Dividend Payout %	0%	0%	0%	0%	63%	0%	0%	0%	13%

* Sales is net of excise duty and discounts

Compounded Sales Growth
10 Years:	%
5 Years:	14.51%
3 Years:	12.74%
TTM:	8.68%

Compounded Profit Growth
10 Years:	%
5 Years:	27.89%
3 Years:	6.66%
TTM:	-0.77%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	-3.18%
1 Year:	35.65%

Return on Equity
10 Years:	%
5 Years:	34.24%
3 Years:	29.80%
Last Year:	24.22%